The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment.
about
Comparative Effectiveness of Biologic Therapy Regimens for Ankylosing Spondylitis: A Systematic Review and a Network Meta-AnalysisRole of HLA-B27 in the pathogenesis of ankylosing spondylitis (Review).Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia.Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23.Pain in ankylosing spondylitis: a neuro-immune collaboration.The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies.Targeted Delivery of the HLA-B∗27-Binding Peptide into the Endoplasmic Reticulum Suppresses the IL-23/IL-17 Axis of Immune Cells in Spondylarthritis.Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy.The Effect of Whole-Body Cryotherapy at Different Temperatures on Proinflammatory Cytokines, Oxidative Stress Parameters, and Disease Activity in Patients with Ankylosing Spondylitis
P2860
Q26764820-A63C39AD-5EC8-4820-94A8-865AD5218080Q37720215-5AC02DC5-78A0-4F79-9CAC-CF3455F6895AQ39024232-29B6CA17-1328-435A-93EE-4A0533D5818EQ39185886-AAD87220-F183-4D7C-966E-D70182A76FEAQ39374230-1E201EBE-05D4-4526-B7FD-D66178A62B15Q40101435-5FB6A95F-8F5C-46F9-8D01-A3AB6C968352Q48093490-2A0F80CD-A5E6-433B-A807-3555D3AF6951Q49788544-22AA56D9-EC9F-4472-B291-1D48D612CC82Q52649775-98F575ED-608D-4F2C-8E5A-C1C9058B6B7BQ58585621-167EA989-8F3A-4385-8EF0-3BB88AC15F0D
P2860
The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The interleukin (IL)-23/IL-17 ...... and potentials for treatment.
@en
type
label
The interleukin (IL)-23/IL-17 ...... and potentials for treatment.
@en
prefLabel
The interleukin (IL)-23/IL-17 ...... and potentials for treatment.
@en
P2860
P356
P1476
The interleukin (IL)-23/IL-17 ...... and potentials for treatment.
@en
P2093
P2860
P356
10.1111/CEI.12670
P50
P577
2015-06-17T00:00:00Z